跳至主要内容
临床试验/ITMCTR1900002625
ITMCTR1900002625招募中1 期

A Randomized Controlled Trial for Neural Circuit Based Taichi Yunshou Action Observation Training Combined With Motor Imagery for Stroke Rehabilitation

ational Natural Science Foundation of China0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. The first cerebral infarction which accords with the diagnosis standard of Chinese and Western medicine and belongs to unilateral brain;
  • 2. Aged 20-75 years, regardless of gender;
  • 3. Right-handed;
  • 4. The onset was more than 1 month and less than 2 years.
  • 5. Primary school and above education level;
  • 6. No severe aphasia (Aphasia Screening Scale);
  • 7. Simple Mental State Scale screening results showed that there was no cognitive impairment.
  • 8. The degree of motor dysfunction of affected limbs was Brunnstrom grade II-VI.
  • 9. It has certain motor imagery function. The motor imagery questionnaire has 25 points or more.
  • 10. Can tolerate half an hour to one hour of training or testing;
  • 11. Volunteer to participate in this study and sign the informed consent.

排除标准

  • 1. Neurological diseases, including epilepsy, which seriously affect the completion of the trial program.
  • 2. there are contraindications of MRI, such as pacemaker, metal implant, etc.
  • 3. Excessive pain exists in limb joints.
  • 4. Cranial fractures and/or severe head injuries;
  • 5. History of head and/or brain surgery;
  • 6. Severe visual or auditory impairment, unable to cooperate with training;
  • 7. Three cycles of antidepressants and psychotropic tranquilizers were taken 30 days before the trial.
  • 8. Other drugs to reduce seizure threshold were taken 30 days before the trial.
  • 9. Severe diseases of liver, kidney, heart, lung and blood system were found.
  • 10. Excessive sensitivity or mental illness;
  • 11. Pregnancy.

研究者

发起方
ational Natural Science Foundation of China

相似试验

eural Circuit Based Taichi Yunshou Action... | 临床试验